# Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection

**Authors:** Komudi Singh, Yun-Ching Chen, Shahin Hassanzadeh, Kim Han, Jennifer T. Judy, Fayaz Seifuddin, Ilker Tunc, Michael N. Sack, Mehdi Pirooznia

PMC · DOI: 10.3389/fgene.2021.599261 · Frontiers in Genetics · 2021-03-16

## TL;DR

This study shows that SARS-CoV-2 disrupts autophagy and mitochondrial processes in host cells, offering new targets for treatment.

## Contribution

The paper identifies unique autophagic and mitochondrial dysfunctions specific to SARS-CoV-2 compared to other viruses.

## Key findings

- SARS-CoV-2 causes downregulation of mTOR and mitochondrial genes in both cell lines and human samples.
- Impaired autophagic flux in SARS-CoV-2-infected cells is linked to increased viral replication.
- Age-related differences in antiviral gene upregulation were observed in SARS-CoV-2-positive human data.

## Abstract

Analyzing host cells' transcriptional response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection will help delineate biological processes underlying viral pathogenesis. First, analysis of expression profiles of lung cell lines A549 and Calu3 revealed upregulation of antiviral interferon signaling genes in response to all three SARS-CoV-2, MERS-CoV, or influenza A virus (IAV) infections. However, perturbations in expression of genes involved in inflammatory, mitochondrial, and autophagy processes were specifically observed in SARS-CoV-2-infected cells. Next, a validation study in infected human nasopharyngeal samples also revealed perturbations in autophagy and mitochondrial processes. Specifically, mTOR expression, mitochondrial ribosomal, mitochondrial complex I, lysosome acidification, and mitochondrial fission promoting genes were concurrently downregulated in both infected cell lines and human samples. SARS-CoV-2 infection impeded autophagic flux either by upregulating GSK3B in lung cell lines or by downregulating autophagy genes, SNAP29, and lysosome acidification genes in human samples, contributing to increased viral replication. Therefore, drugs targeting lysosome acidification or autophagic flux could be tested as intervention strategies. Finally, age-stratified SARS-CoV-2-positive human data revealed impaired upregulation of chemokines, interferon-stimulated genes, and tripartite motif genes that are critical for antiviral signaling. Together, this analysis has revealed specific aspects of autophagic and mitochondrial function that are uniquely perturbed in SARS-CoV-2-infected host cells.

## Linked entities

- **Genes:** GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], SNAP29 (synaptosome associated protein 29) [NCBI Gene 9342], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475]
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** NDUFV1 (NADH:ubiquinone oxidoreductase core subunit V1) [NCBI Gene 4723] {aka CI-51K, CI51KD, MC1DN4, UQOR1}, SKP2 (S-phase kinase associated protein 2) [NCBI Gene 6502] {aka FBL1, FBXL1, FLB1, p45}, C1S (complement C1s) [NCBI Gene 716] {aka EDSPD2}, ULK1 (unc-51 like autophagy activating kinase 1) [NCBI Gene 8408] {aka ATG1, ATG1A, UNC51, Unc51.1, hATG1}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, TRIM5 (tripartite motif containing 5) [NCBI Gene 85363] {aka RNF88, TRIM5alpha}, MRPL20 (mitochondrial ribosomal protein L20) [NCBI Gene 55052] {aka L20mt, MRP-L20, bL20m}, MITF (melanocyte inducing transcription factor) [NCBI Gene 4286] {aka CMM8, COMMAD, MI, MITF-A, WS2, WS2A}, PARK7 (Parkinsonism associated deglycase) [NCBI Gene 11315] {aka DJ-1, DJ1, GATD2, HEL-S-67p}, CXCR5 (C-X-C motif chemokine receptor 5) [NCBI Gene 643] {aka BLR1, CD185, MDR15}, SQSTM1 (sequestosome 1) [NCBI Gene 8878] {aka A170, DMRV, EBIAP, FTDALS3, NADGP, OSIL}, IFIT1 (interferon induced protein with tetratricopeptide repeats 1) [NCBI Gene 3434] {aka C56, G10P1, IFI-56, IFI-56K, IFI56, IFIT-1}, TLR3 (toll like receptor 3) [NCBI Gene 7098] {aka CD283, IIAE2, IMD83}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}, BECN1 (beclin 1) [NCBI Gene 8678] {aka ATG6, VPS30, beclin1}, RPTOR (regulatory associated protein of MTOR complex 1) [NCBI Gene 57521] {aka KOG1, Mip1}, C1QTNF6 (C1q and TNF related 6) [NCBI Gene 114904] {aka CTFP6, CTRP6, ZACRP6}, MTFP1 (mitochondrial fission process 1) [NCBI Gene 51537] {aka HSPC242, MTP18}, TRIM38 (tripartite motif containing 38) [NCBI Gene 10475] {aka RNF15, RORET}, CXCL11 (C-X-C motif chemokine ligand 11) [NCBI Gene 6373] {aka H174, I-TAC, IP-9, IP9, SCYB11, SCYB9B}, MARCKSL1 (MARCKS like 1) [NCBI Gene 65108] {aka F52, MACMARCKS, MLP, MLP1, MRP}, IFIT3 (interferon induced protein with tetratricopeptide repeats 3) [NCBI Gene 3437] {aka CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, ATG5 (autophagy related 5) [NCBI Gene 9474] {aka APG5, APG5-LIKE, APG5L, ASP, SCAR25, hAPG5}, TMPRSS2 (transmembrane serine protease 2) [NCBI Gene 7113] {aka PRSS10}, TRAF3 (TNF receptor associated factor 3) [NCBI Gene 7187] {aka CAP-1, CD40bp, CRAF1, IIAE5, IMD132A, IMD132B}, TRIM22 (tripartite motif containing 22) [NCBI Gene 10346] {aka GPSTAF50, RNF94, STAF50}, ADAP2 (ArfGAP with dual PH domains 2) [NCBI Gene 55803] {aka CENTA2, HSA272195, cent-b}, TMPRSS4 (transmembrane serine protease 4) [NCBI Gene 56649] {aka CAP2, CAPH2, MT-SP2, TMPRSS3}, CCR5 (C-C motif chemokine receptor 5) [NCBI Gene 1234] {aka CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, C1R (complement C1r) [NCBI Gene 715] {aka EDS8, EDSPD1}, SOCS6 (suppressor of cytokine signaling 6) [NCBI Gene 9306] {aka CIS-4, CIS4, HSPC060, SOCS-4, SOCS-6, SOCS4}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], WARS1 (tryptophanyl-tRNA synthetase 1) [NCBI Gene 7453] {aka GAMMA-2, HMN9, HMND9, IFI53, IFP53, NEDMSBA}, MRPL43 (mitochondrial ribosomal protein L43) [NCBI Gene 84545] {aka L43mt, MRP-L43, bMRP36a, mL43}, ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272] {aka ACEH}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, NRP1 (neuropilin 1) [NCBI Gene 8829] {aka BDCA4, CD304, NP1, NRP, VEGF165R}, MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}, SNAP29 (synaptosome associated protein 29) [NCBI Gene 9342] {aka CEDNIK, SNAP-29}, IFIT2 (interferon induced protein with tetratricopeptide repeats 2) [NCBI Gene 3433] {aka G10P2, GARG-39, IFI-54, IFI-54K, IFI54, IFIT-2}
- **Diseases:** respiratory failure (MESH:D012131), arthritis (MESH:D001168), fatigue (MESH:D005221), IAV (MESH:D007251), enteroviral infections (MESH:D007239), pancreatic cancer (MESH:D010190), thrombosis (MESH:D013927), fever (MESH:D005334), cough (MESH:D003371), SARS (MESH:D045169), Inflammation (MESH:D007249), respiratory distress (MESH:D012128), hypertension (MESH:D006973), diabetes (MESH:D003920), retroviral (MESH:D000071297), upper respiratory infections (MESH:D012141), lung carcinoma (MESH:D008175), MERS-CoV (MESH:D018352), cardiac injury (MESH:D006331), Autophagic and Mitochondrial Dysfunctions (MESH:D028361), COVID-19 infection (MESH:D000086382), cancer (MESH:D009369), Viral infection (MESH:D014777)
- **Chemicals:** ROS (MESH:D017382), tocilizumab (MESH:C502936), oxygen (MESH:D010100), OC43 (-)
- **Species:** Orthocoronavirinae (subfamily) [taxon 2501931], Betacoronavirus (genus) [taxon 694002], Severe acute respiratory syndrome-related coronavirus (no rank) [taxon 694009], Mus musculus (house mouse, species) [taxon 10090], Murine hepatitis virus (no rank) [taxon 11138], Middle East respiratory syndrome-related coronavirus (no rank) [taxon 1335626], Macaca (macaque, genus) [taxon 9539], Adenoviridae (family) [taxon 10508], Cercopithecidae (monkey, family) [taxon 9527], Influenza A virus (no rank) [taxon 11320], Betacoronavirus 1 (no rank) [taxon 694003], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606], Candidatus Accumulibacter adiacens (species) [taxon 2954378]
- **Cell lines:** NCI-H1299 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_0060), HCT-8 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_2478), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), Calu 3 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0609), CCL- — Mus musculus (Mouse), Undefined cell line type (CVCL_M023), VR-1558D — Homo sapiens (Human), Transformed cell line (CVCL_2H22)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC8008150/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC8008150/full.md

## References

110 references — full list in the complete paper: https://tomesphere.com/paper/PMC8008150/full.md

---
Source: https://tomesphere.com/paper/PMC8008150